Twice as many people as previously believed are dying of sepsis worldwide, according to a new analysis. Among them are a disproportionately high number of children in poor areas.
The 6KApoEp, also known as peptide antagonist, was shown to reduce Alzheimer’s-associated beta-amyloid (β-amyloid) accumulation and tau pathologies in the brain, as well as improving learning and memory in mice genetically engineered to mimic symptoms of Alzheimer’s disease